Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
- 1 October 2008
- Vol. 113 (S7), 1953-1968
- https://doi.org/10.1002/cncr.23741
Abstract
Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences between studies in patients, tumor types, and methods of classification. Individual studies generally have lacked samples of sufficient size to examine interactions. A major priority based on available evidence and technologies includes expanding research in genetics and molecular epidemiology of brain tumors. BTEC has taken an active role in promoting understudied groups, such as pediatric brain tumors; the etiology of rare glioma subtypes, such as oligodendroglioma; and meningioma, which, although it is not uncommon, has only recently been registered systematically in the United States. There also is a pressing need for more researchers, especially junior investigators, to study brain tumor epidemiology. However, relatively poor funding for brain tumor research has made it difficult to encourage careers in this area. In this report, BTEC epidemiologists reviewed the group's consensus on the current state of scientific findings, and they present a consensus on research priorities to identify which important areas the science should move to address.Keywords
This publication has 147 references indexed in Scilit:
- Detection of human cytomegalovirus in different histological types of gliomasActa Neuropathologica, 2008
- The INTERPHONE study: design, epidemiological methods, and description of the study populationEuropean Journal of Epidemiology, 2007
- Mobile phone use and risk of acoustic neuroma: results of the interphone case–control study in five North European countriesBritish Journal of Cancer, 2006
- Lung cancer and exposure to environmental cadmiumThe Lancet Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- Gene expression profiling and subgroup identification of oligodendrogliomasOncogene, 2004
- Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991Journal of Neurosurgery, 1998
- Environmental risk factors for primary malignant brain tumors: A reviewJournal of Neuro-Oncology, 1993
- Tumors of the Brain and Nervous System after Radiotherapy in ChildhoodThe New England Journal of Medicine, 1988
- Cadmium — A complex environmental problem Part IICellular and Molecular Life Sciences, 1984